Axon Enterprise, Inc. (NASDAQ:AXON) Shares Bought by Penserra Capital Management LLC

Penserra Capital Management LLC grew its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 12.6% during the third quarter, Holdings Channel reports. The firm owned 6,297 shares of the biotechnology company’s stock after purchasing an additional 706 shares during the quarter. Penserra Capital Management LLC’s holdings in Axon Enterprise were worth $2,516,000 at the end of the most recent quarter.

Other hedge funds have also made changes to their positions in the company. Blue Trust Inc. lifted its holdings in Axon Enterprise by 987.5% during the 2nd quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock worth $27,000 after buying an additional 79 shares in the last quarter. Quent Capital LLC raised its stake in shares of Axon Enterprise by 1,875.0% in the third quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock valued at $32,000 after acquiring an additional 75 shares in the last quarter. Asset Dedication LLC purchased a new position in Axon Enterprise in the second quarter valued at $47,000. Planning Capital Management Corp grew its stake in Axon Enterprise by 83.3% during the 3rd quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock worth $48,000 after purchasing an additional 55 shares in the last quarter. Finally, Friedenthal Financial purchased a new stake in Axon Enterprise during the 3rd quarter worth about $51,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Axon Enterprise Trading Down 2.8 %

AXON opened at $619.00 on Tuesday. The firm has a market cap of $47.20 billion, a price-to-earnings ratio of 159.95, a price-to-earnings-growth ratio of 14.02 and a beta of 0.94. Axon Enterprise, Inc. has a 52 week low of $224.28 and a 52 week high of $641.20. The business’s 50 day moving average is $468.24 and its two-hundred day moving average is $370.65. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32.

Insider Activity

In other Axon Enterprise news, Director Julie A. Cullivan sold 900 shares of Axon Enterprise stock in a transaction that occurred on Thursday, September 5th. The stock was sold at an average price of $353.53, for a total value of $318,177.00. Following the transaction, the director now directly owns 3,653 shares in the company, valued at approximately $1,291,445.09. This trade represents a 19.77 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Jeffrey C. Kunins sold 21,834 shares of the business’s stock in a transaction on Tuesday, November 12th. The shares were sold at an average price of $593.88, for a total transaction of $12,966,775.92. Following the completion of the transaction, the insider now directly owns 154,394 shares in the company, valued at $91,691,508.72. This represents a 12.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 260,256 shares of company stock valued at $105,984,120 in the last ninety days. 5.70% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

AXON has been the subject of a number of analyst reports. The Goldman Sachs Group boosted their price objective on Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a research report on Wednesday, October 23rd. Needham & Company LLC increased their price objective on shares of Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research report on Friday, November 8th. Robert W. Baird lifted their price objective on shares of Axon Enterprise from $440.00 to $460.00 and gave the stock an “outperform” rating in a research report on Monday, November 4th. Craig Hallum increased their target price on Axon Enterprise from $370.00 to $376.00 and gave the company a “buy” rating in a report on Wednesday, August 7th. Finally, Northland Securities lifted their price target on Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a report on Monday, November 11th. Two equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $427.83.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.